# Second-Pass Scientific and Report-Quality Review

## A. Overall verdict

**Minor revision.** The draft is scientifically coherent and follows the supervisor template. Frozen numerical results, benchmark populations, A3 usability/quality denominators, and source-grounded terminology were checked. No new experiment is needed. Before finalization, complete the verified bibliography, insert the selected figures/tables, replace screenshot placeholders with genuinely captured local-prototype views, and apply the template’s DOCX formatting.

The review does not overwrite `FINAL_REPORT_DRAFT.md` and does not modify frozen artifacts.

## B. Template compliance

All required template sections are present:

- Section 1: Project Overview; 1.1 Problem Statement; 1.2 Research Objectives; 1.3 Research Questions / Hypotheses.
- Section 2: Related Work & Research Gap.
- Section 3: Proposed Method; 3.1 Overall Approach; 3.2 Method / Architecture; 3.3 Implementation.
- Section 4: Experimental Design & Evaluation; 4.1 Baselines; 4.2 Evaluation Metrics; 4.3 Experimental Setup.
- Section 5: Results, Findings & Analysis; 5.1 Key Results and Findings; 5.2 Analysis; 5.3 Research / Project Implications.
- Section 7: Limitations.
- Section 8: Prototype / System Demonstration; 8.1 Prototype Overview; 8.2 Key Features; 8.3 Demonstration Results.
- Section 9: Conclusion & Future Work; 9.1 Conclusion; 9.2 Future Work.
- Section 10: References.

Section 6 remains absent, matching the official template. No required section is missing. Section 5 is appropriately the longest section. Approximate section word counts are: 1 (465), 2 (578), 3 (495), 4 (544), 5 (816), 7 (280), 8 (251), 9 (316), and 10 (118), for approximately 3,941 words including headings and placeholders. This is balanced for a first draft; adding filler is not recommended.

## C. RQ-by-RQ assessment

| RQ | Supporting experiments | Strongest evidence | Supported answer | Caveat |
|---|---|---|---|---|
| RQ1: retrieval strategy and downstream source-grounded quality | Retrieval Ablation selection/confirmation; RQ1 C1/C2 confirmatory comparison | R3 selection Recall@4 reached 1.00 on the 40-question selection set, but R3 confirmation Full Recall was 76.67% versus R0 80.00% (paired CI crossed zero; McNemar p=0.7744). | Retrieval ranking quality and downstream answer quality are distinct; better selection metrics did not demonstrate better generation. | Selection and confirmation are separate populations; the result is conditional on the tested corpus, prompts, and retrieval configurations. |
| RQ2: agent architecture, debate, and checkpoint diversity | RQ1 C1/C2; RQ4 C2/C4; A3 v1.3 M1/M2 | C1/C2 was essentially tied; C4 had lower Full Recall, lower usability, and much higher latency; M2 had a higher quality point estimate but 78% versus 96% usability. | Added architecture or debate complexity did not consistently improve source-grounded completeness; heterogeneity may raise a point estimate at substantial operational cost. | RQ4 is a same-model one-round debate comparison; A3 M2 confounds heterogeneity with checkpoint capability and is not three independent model families. |
| RQ3: evidence-aware judging and conflict-aware governance | Research B and Research C | J2 Accuracy/Macro-F1 greatly exceeded J1; K2 improved citation coverage, viewpoint preservation, uncertainty signalling, and conflict transparency while Macro-F1 was slightly lower. | Evidence access is the clearest positive judging result; conflict governance mainly improved transparency rather than aggregate classification. | These are source-grounded benchmark outcomes, not clinical correctness or expert adjudication. |
| RQ4: integrated evidence, conflict, safety, and evidence-confidence signals | Integrated backend/frontend validation and six deterministic demo cases | The typed integrated response exposes evidence support, conflict status, source-grounded safety findings/score, evidence confidence, penalties/caps, and citations; all six offline demo cases passed. | The signals can be composed into an explainable local research response while retaining legacy/null behavior. | Demo validation is interface-level and non-formal; SafeJudge and Confidence Judge remain deterministic prototype governance indicators without independent calibration. |

## D. Scientific claim issues

No material scientific overclaim or numerical transcription error was found. The draft correctly:

- avoids claiming a clear Multi-Agent quality improvement in A1/RQ1;
- states that same-model debate did not improve Full Recall and increased cost;
- separates retrieval selection from downstream confirmation;
- limits Research B’s large gain to source-grounded classification;
- describes Research C as a transparency/evidence-coverage result rather than an aggregate accuracy gain;
- reports A3 M2 as a higher point estimate with exact McNemar p=0.0703125, not confirmatory significance;
- separates A3 semantic quality (76 complete usable pairs) from usability (100 scheduled executions per condition);
- describes SafeJudge and evidence confidence as deterministic source-grounded governance signals;
- describes semantic review and corpus provenance without treating either as clinical validation.

Three minor editorial issues should be addressed before finalization:

1. Replace implementation-note wording such as “the final integration patch adds” with report prose such as “the integrated interface includes.”
2. Keep the caveat language concise and consistent; use “source-grounded research signal” and “response reliability indicator” throughout rather than alternating formulations.
3. In the final DOCX, replace figure placeholders with captions and figures, and move dense confidence intervals/p-values into compact tables where page space is limited.

## E. Benchmark/population issues

No population error was found. The draft correctly keeps A1/RQ1 separate from A2/RQ4, retrieval selection separate from retrieval confirmation, and A3 complete-pair quality separate from all-execution usability. It explicitly states that unusable A3 conditions are not semantic zeroes. The reported N values are internally consistent with the frozen source map: RQ1 100 held-out questions; RQ4 90 represented questions and 80 complete usable pairs; Research B 240 cases and 480 judge executions; Research C 132 conflict cases including 12 direct conflicts; A3 100 executions per condition and 76 complete usable pairs.

## F. Results-section issues

Section 5 communicates the five requested major findings with numerical evidence, interpretation, and trade-offs. It also includes conflict transparency as an additional governance result. The separation between results and analysis is clear, repetition is limited, and the “why this matters” implication is stated: evidence discipline, downstream validation, usability, latency, and transparency must be evaluated together.

Recommended final layout: retain the five finding paragraphs, keep exact confidence intervals and p-values in tables or figure notes, and avoid repeating the full statistics again in the conclusion.

## G. Figure/table recommendations

All eight final clean figures exist and their current mappings, captions, and denominators are documented in `FIGURE_PLACEMENT.md`.

**Essential for the main report:** Figure 1 (architecture), Figure 2b (retrieval downstream), Figure 3a (RQ4 quality/usability), Figure 4 (evidence-aware judging), and Figure 5a (A3 quality/usability).

**Optional if the report becomes visually crowded:** Figure 2a (selection-stage retrieval), Figure 3b (RQ4 latency), and Figure 5b (A3 latency). These can be retained in an appendix or combined with compact tables. Exact CIs, p-values, denominators, and latency values are better presented in tables/notes than inferred from bars.

No figure caption makes an unsupported clinical or statistical claim. Preserve the source mappings; do not substitute the failed retrieval-connectivity artifact for the successful frozen retrieval figures.

## H. Writing/style issues

The draft uses academic but readable English and generally uses the required cautious forms (“under the tested configuration,” “did not demonstrate,” “point estimate,” and “associated with”). It avoids marketing language and does not use “proved” or “guaranteed.” The main style pass should shorten a few long paragraphs in Sections 2 and 4, convert the prototype “patch” wording noted above, and keep “evidence confidence” distinct from agent self-confidence.

## I. Reference gaps

The five placeholders are appropriate and must not be filled from memory:

1. **Foundational RAG paper:** needed to support the definition and motivation of retrieval-augmented generation in Sections 1–2. Search: “retrieval-augmented generation original paper evidence passages.”
2. **Multi-agent reasoning/debate study:** needed to situate specialist decomposition, critique, and consensus in Section 2. Search: “multi-agent large language model debate reasoning empirical evaluation.”
3. **LLM-as-a-Judge/evaluation study:** needed to support the evidence-access distinction in Research B and Section 2. Search: “LLM as a judge claim evidence evaluation paper.”
4. **Healthcare RAG/evidence-grounded QA study:** needed for the domain-specific motivation and limitations in Sections 1–2. Search: “healthcare retrieval augmented generation evidence grounded question answering.”
5. **TCM RAG/traditional-medicine QA study:** needed to position the TCM-focused corpus and prototype in the domain literature. Search: “traditional Chinese medicine retrieval augmented generation question answering.”

Each source should be independently verified for authors, title, venue, year, and persistent identifier before replacing a placeholder.

## J. Exact edits recommended before finalization

1. Apply the three minor editorial wording edits in Section D; do not change any numerical result or research question.
2. Complete the five references only from independently verified sources.
3. Insert the essential figures using `FIGURE_PLACEMENT.md`; use tables for dense statistics and retain denominator notes.
4. Capture screenshot placeholders A–D from the validated local prototype only; do not imply a deployed clinical system.
5. Apply the official DOCX template formatting, author metadata, and supervisor-required page details after Markdown approval. The original template remains untouched.
6. Perform one final copy-edit and hyperlink/source-path check. No new experiment, provider call, or frozen-artifact edit is warranted.

## Validation record

- V1 draft changed: **NO**.
- Frozen numerical values changed: **NO**.
- Frozen artifacts modified: **NO**.
- Provider/API calls: **NONE**.
- References fabricated: **NO**.
- Screenshot placeholders retained: **YES**.
